ArticleAnnals of translational medicine2026
Bronchoscopic photodynamic therapy for endobronchial metastatic papillary thyroid carcinoma causing lobar airway obstruction: a case report.
Article in Annals of translational medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Bronchoscopic photodynamic therapy (PDT) is a guideline-supported, non-thermal modality for malignant central airway obstruction. It may be particularly advantageous for hypervascular endobronchial tumors in which immediate mechanical or thermal debulking carries heightened hemorrhage risk. While PDT is well described in primary lung malignancies, published experience in non-lung-primary endobronchial metastases remains limited. Case Description: A 71-year-old never-smoking woman with advanced radioactive iodine (RAI)-refractory BRAF V600E-mutated papillary thyroid carcinoma (PTC) with pulmonary, brain, and bone metastases presented with imaging evidence of a left lower lobe (LLL) lesion with endobronchial extension. Bronchoscopy demonstrated a friable, highly vascular endobronchial tumor causing approximately 90% obstruction of the LLL bronchus and a smaller non-occlusive lesion in the superior segment of the right lower lobe (RLL). Given lesion vascularity and bleeding-risk concerns with immediate debulking, a staged PDT approach was selected. Porfimer sodium [Photofrin; 2 mg/kg intravenous (IV)] was administered, followed by bronchoscopic light activation (630 nm) using a 2-cm cylindrical diffuser fiber. PDT was delivered to both lesions (100 J over 250 seconds per site). A repeat bronchoscopy 72 hours later demonstrated approximately 50% airway lumen improvement following removal of necrotic tissue and mucus, and PDT was repeated with identical parameters. Subsequent re-evaluation demonstrated necrotic post-PDT changes, and adjunctive cryodebulking was performed. Pathology confirmed metastatic PTC. Follow-up chest computed tomography demonstrated recanalization of the LLL bronchus and mild decrease in the dominant LLL mass. Conclusions: Staged bronchoscopic PDT and adjunct cryotherapy provided effective local airway control for hypervascular endobronchial metastatic PTC causing lobar obstruction, with complete response of a smaller non-obstructive RLL lesion, without major bleeding or airway compromise. PDT may be a safe and effective adjunctive therapy for selected patients with metastatic endobronchial PTC.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.